Rotational Atherectomy, Lithotripsy, or Laser for Calcified Coronary Stenosis: One‐Year Outcomes From the ROLLER COASTER‐EPIC22 Trial
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.31529 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Mattia Basile und 16 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, La Paz University Hospital, Madrid, Spain. Hauptthemen laut MEDLINE: Atherectomy, Coronary, Vascular Calcification, Coronary Stenosis, Coronary Artery Disease. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: This study was supported by an unrestricted grant from Fundación EPIC..
Abstract (Originalsprache)
Background
The ROLLER COASTR‐EPIC22 was the first randomized trial to directly compare rotational atherectomy (RA), excimer laser coronary angioplasty (ELCA), and intravascular lithotripsy (IVL) for the treatment of patients with calcified coronary stenosis.
Aims
The aim of this study is to report and compare its 1‐year clinical outcomes.
Methods
The ROLLER COASTR‐EPIC22 trial randomized 171 patients with angiographic moderate to severe calcified coronary lesions to PCI with RA ( n = 57), IVL ( n = 57), or ELCA ( n = 57). A pre‐specified analysis of clinical events at one year from the index PCI was conducted. The clinical endpoints analyzed at one year were the rate of major adverse cardiovascular events (MACE), defined as the occurrence of cardiac death, target vessel myocardial infarction (TV‐MI), target lesion revascularization (TLR), target vessel revascularization (TVR) and stent thrombosis. Furthermore, the rate of all‐cause mortality, non‐fatal TV‐MI, TVR, TLR, and stent thrombosis were analyzed separately. Kaplan‐Meier analysis was performed to assess time‐to‐event outcomes. The adjudication of clinical events was conducted in accordance with the intention‐to‐treat principle.
Results
The mean age was 70.9 ± 8.2 years and 77.2% of the patients were men. Clinical presentation was acute coronary syndrome in 35.7% of patients and severe angiographic calcification was observed in 82.5% of lesions by the independent core laboratory unaware to the treatment arm. All patients showed criteria of severe calcification, either angiographic or at optical coherence tomography (OCT). At OCT evaluation, mean calcium arc was 300.8° ± 78.9°, maximum calcium thickness 1.17 ± 0.24 mm, calcification length 30.9 ± 12.9 mm and 30.5% of patients presented calcium nodules. Baseline characteristics were well balanced between groups. At one year, there were no significant differences in MACE incidence among the three arms (RA 5.3%, IVL 5.3%, ELCA 3.5%; p = 0.88). Furthermore, there were no significant differences in all‐cause death between groups ( p = 0.22), with no events in the IVL group (RA 5.3%, IVL 0%, ELCA 5.3%). No significant differences were observed among the 3 arms in the terms of TV‐MI (RA 1.7, IVL 1.7, ELCA 0%; p = 0.61), TVR (RA 3.5%, IVL 5.3%, ELCA 1.7%; p = 0.59), TLR (RA 1.7%, IVL 1.7%, ELCA 1.7%; p = 1.00), or stent thrombosis (RA 1.7%, IVL 0%, ELCA 1.7; p = 0.61).
Conclusions
This is the first randomized trial comparing RA, IVL, and ELCA for the treatment of patients with calcified coronary lesions and reporting long‐term clinical outcomes. At one year, no significant differences were observed among the three arms in the composite endpoint of one‐year all‐cause mortality, AMI, TVR, TLR and stent thrombosis. Similarly, no significant differences were found when analyzing the individual components of the endpoint separately.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiology Department, La Paz University Hospital, Madrid, Spain.
- Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
- Cardiology Department, University Hospital Juan Ramón Jiménez, Huelva, Spain.
- Fundación de Investigación IDIPAZ, Madrid, Spain.
- Cardiology Department, Hospital Clínico Universitario Valladolid, Valladolid, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares, Madrid, Spain.
ORCID-Profile: Mattia Basile, Borja Rivero-Santana, Ignacio J Amat-Santos, Soledad Ojeda, Ariana Gonzálvez-García, Daniel Tébar-Márquez, Alfonso Jurado-Román
Förderung
- This study was supported by an unrestricted grant from Fundación EPIC.
Zitieren
APA
Basile, M., Gómez-Menchero, A., Rivero-Santana, B., Amat-Santos, I. J., Jiménez-Valero, S., Caballero-Borrego, J., Ojeda, S., Miñana, G., Gonzálvez-García, A., Tébar-Márquez, D., Roa-Garrido, M. J., Camacho-Freire, S., Ocaranza-Sánchez, R., Domínguez, A., Galeote, G., Moreno, R., & Jurado-Román, A. (2025). Rotational Atherectomy, Lithotripsy, or Laser for Calcified Coronary Stenosis: One‐Year Outcomes From the ROLLER COASTER‐EPIC22 Trial. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31529
Vancouver
Basile M, Gómez-Menchero A, Rivero-Santana B, Amat-Santos IJ, Jiménez-Valero S, Caballero-Borrego J, et al. Rotational Atherectomy, Lithotripsy, or Laser for Calcified Coronary Stenosis: One‐Year Outcomes From the ROLLER COASTER‐EPIC22 Trial. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31529
BibTeX
@article{Basile2025,
author = {Basile, Mattia and Gómez-Menchero, Antonio and Rivero-Santana, Borja and Amat-Santos, Ignacio J and Jiménez-Valero, Santiago and Caballero-Borrego, Juan and Ojeda, Soledad and Miñana, Gema and Gonzálvez-García, Ariana and Tébar-Márquez, Daniel and Roa-Garrido, Maria Jessica and Camacho-Freire, Santiago and Ocaranza-Sánchez, Raymundo and Domínguez, Antonio and Galeote, Guillermo and Moreno, Raúl and Jurado-Román, Alfonso},
title = {Rotational Atherectomy, Lithotripsy, or Laser for Calcified Coronary Stenosis: One‐Year Outcomes From the ROLLER COASTER‐EPIC22 Trial},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.31529}
}
EUVIMED